Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference

Company Overview - Anika Therapeutics, Inc. is a global joint preservation company focused on early intervention orthopedic care [3] - The company specializes in hyaluronic acid and implant solutions, aiming to provide minimally invasive products for active living [3] - Anika's operations are headquartered outside of Boston, Massachusetts, and it targets high opportunity areas within orthopedics, such as Osteoarthritis Pain Management and Regenerative Solutions [3] Upcoming Event - Dr. Cheryl Blanchard, President and CEO of Anika, will present at the Canaccord Genuity 2025 Musculoskeletal Conference on March 10, 2025 [1] - The presentation will be available via live webcast and archived for 30 days on Anika's website [2] - Management will also engage in one-on-one investor meetings during the conference [1]